Michelle Vuolo
About Michelle Vuolo
Michelle Vuolo serves as the Head of Quality at Tulip Interfaces, bringing extensive experience in pharmaceutical quality systems and compliance. She has held previous leadership roles at Sanofi and Genzyme and possesses specialized skills in lifecycle management of computer systems.
Work at Tulip Interfaces
Michelle Vuolo has been serving as the Head of Quality at Tulip Interfaces since 2020. In this role, she is responsible for overseeing quality assurance processes and ensuring compliance with industry standards. Her leadership contributes to the company's commitment to maintaining high-quality products and services in the technology sector. Tulip Interfaces, located in Somerville, Massachusetts, focuses on enhancing operational efficiency through innovative solutions.
Previous Experience at Sanofi
Prior to her current role, Michelle Vuolo worked at Sanofi as the Director of Computer Systems Compliance from 2013 to 2019. During her six years in Westborough, MA, she was involved in ensuring that computer systems met regulatory compliance standards. Her experience in this position reinforced her expertise in quality management within the pharmaceutical industry.
Experience at Genzyme
Michelle Vuolo held the position of Associate Director of Corporate QA Enterprise Systems at Genzyme from 1996 to 2013. Over her 17-year tenure, she developed a strong foundation in pharmaceutical quality systems. This role allowed her to gain extensive knowledge in maintaining quality and compliance in pharmaceutical operations, which has been a significant aspect of her career.
Education and Expertise
Michelle Vuolo earned her Bachelor of Science degree in Chemical Engineering from the University of Massachusetts Amherst, where she studied from 1991 to 1995. Her educational background supports her specialized skills in lifecycle management of computer systems, focusing on electronic records and signatures. She is also a certified lead auditor, demonstrating her proficiency in assessing quality standards across various industries.
Leadership in ISPE
Since 2019, Michelle Vuolo has been the ISPE Validation 4.0 Working Group Lead within the Pharma 4.0 Special Interest Group. In this capacity, she contributes to advancing methodologies critical for compliance and quality in the biopharmaceutical sector. Her involvement in ISPE reflects her commitment to enhancing industry standards and practices.